1. Home
  2. STOK vs SBC Comparison

STOK vs SBC Comparison

Compare STOK & SBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • SBC
  • Stock Information
  • Founded
  • STOK 2014
  • SBC 2000
  • Country
  • STOK United States
  • SBC United States
  • Employees
  • STOK N/A
  • SBC N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • SBC
  • Sector
  • STOK Health Care
  • SBC
  • Exchange
  • STOK Nasdaq
  • SBC NYSE
  • Market Cap
  • STOK 379.6M
  • SBC 333.6M
  • IPO Year
  • STOK 2019
  • SBC N/A
  • Fundamental
  • Price
  • STOK $7.69
  • SBC $4.02
  • Analyst Decision
  • STOK Strong Buy
  • SBC
  • Analyst Count
  • STOK 6
  • SBC 0
  • Target Price
  • STOK $26.00
  • SBC N/A
  • AVG Volume (30 Days)
  • STOK 987.9K
  • SBC 25.5K
  • Earning Date
  • STOK 05-05-2025
  • SBC 05-23-2025
  • Dividend Yield
  • STOK N/A
  • SBC N/A
  • EPS Growth
  • STOK N/A
  • SBC 15.50
  • EPS
  • STOK N/A
  • SBC 0.48
  • Revenue
  • STOK $36,555,000.00
  • SBC $205,415,542.00
  • Revenue This Year
  • STOK $27.80
  • SBC N/A
  • Revenue Next Year
  • STOK $9.53
  • SBC $10.31
  • P/E Ratio
  • STOK N/A
  • SBC $8.33
  • Revenue Growth
  • STOK 316.34
  • SBC 6.13
  • 52 Week Low
  • STOK $5.35
  • SBC $2.62
  • 52 Week High
  • STOK $17.58
  • SBC $36.52
  • Technical
  • Relative Strength Index (RSI)
  • STOK 53.59
  • SBC N/A
  • Support Level
  • STOK $7.31
  • SBC N/A
  • Resistance Level
  • STOK $7.99
  • SBC N/A
  • Average True Range (ATR)
  • STOK 0.61
  • SBC 0.00
  • MACD
  • STOK 0.23
  • SBC 0.00
  • Stochastic Oscillator
  • STOK 88.64
  • SBC 0.00

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About SBC SBC MEDICAL GROUP HOLDINGS INCRPRTD

SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). They provide management services to a total of One hundred fifty eight franchisee treatment centers under the brand name Shonan Beauty Clinic located in Japan.

Share on Social Networks: